P-2433 |
pTH (73-84) (human) |
C54H96N16O19 |
1273.45 |
? |
H-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH |
P-2501 |
M65, PAC1 Receptor Antagonist M65 |
C199H314N62O60S5 |
4695.39 |
? |
H-Cys-Asp-Ala-Thr-Cys-Gln-Phe-Arg-Lys-Ala-Ile-Asp-Asp-Cys-Gln-Lys-Gln-Ala-His-His-Ser-Asn-Val-Pro-Gly-Asn-Ser-Val-Phe-Lys-Glu-Cys-Met-Lys-Gln-Lys-Lys-Glu-Phe-Lys-Ala-NH2 (Disulfide bonds between Cys1 and Cys?/Cys1? and Cys32) |
P-2502 |
Maxadilan |
C291H466N86O94S6 |
6865.82 |
135374-80-0 |
H-Cys-Asp-Ala-Thr-Cys-Gln-Phe-Arg-Lys-Ala-Ile-Asp-Asp-Cys-Gln-Lys-Gln-Ala-His-His-Ser-Asn-Val-Leu-Gln-Thr-Ser-Val-Gln-Thr-Thr-Ala-Thr-Phe-Thr-Ser-Met-Asp-Thr-Ser-Gln-Leu-Pro-Gly-Asn-Ser-Val-Phe-Lys-Glu-Cys-Met-Lys-Gln-Lys-Lys-Lys-Glu-Phe-Lys-Ala-NH2 (Disulfide bonds between Cys1 and Cys?/Cys1? and Cys?1) |
P-2601 |
H-Phe-Gly-Phe-Gly-OH |
C22H26N4O5 |
426.47 |
59005-83-3 |
H-Phe-Gly-Phe-Gly-OH |
P-2602 |
H-D-Tyr-Val-NH2 |
C14H21N3O3 |
279.34 |
87237-39-6 |
H-D-Tyr-Val-NH2 |
P-2603 |
H-D-Tyr-Val-Gly-OH |
C16H23N3O5 |
337.38 |
86030-52-6 |
H-D-Tyr-Val-Gly-OH |
P-2701 |
Ac-Ala-Ala-Ser(PO3H2)-Pro-Arg-pNA |
C28H43N10O12P |
742.68 |
202739-37-5 |
Ac-Ala-Ala-Ser(PO3H2)-Pro-Arg-pNA |
P-2702 |
Suc-Ala-Ala-Pro-Phe-AMC |
C34H39N5O9 |
661.71 |
88467-45-2 |
Suc-Ala-Ala-Pro-Phe-AMC |
P-2703 |
Suc-Ala-Ala-Pro-Phe-2,4-difluoroanilide |
C30H35F2N5O7 |
615.63 |
381164-12-1 |
Suc-Ala-Ala-Pro-Phe-2,4-difluoroanilide |
P-2704 |
Suc-Ala-Ala-Pro-Phe-pNA |
C30H36N6O9 |
624.65 |
70967-97-4 |
Suc-Ala-Ala-Pro-Phe-pNA |